Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.64

€1.64

1.550%
0.025
1.550%
€2.50

€2.50

 
11:27 / Tradegate WKN: A2JQSC / Symbol: TLRY / Name: Tilray / Stock / Mid Cap /
Latest predictions
16.09.24
1.67%
buy
11.09.24
7.32%
buy
28.08.24
6.97%
buy
27.08.24
2.63%
27.08.24
3.47%
buy
€3.00
20.03.24
-8.09%
buy
Your prediction

Tilray Inc Stock

Tilray Inc gained 1.550% today.
We see a rather positive sentiment for Tilray Inc with 6 Buy predictions and 2 Sell predictions.
With a target price of 2 € there is a positive potential of 21.84% for Tilray Inc compared to the current price of 1.64 €.
Our community identified positive and negative aspects for Tilray Inc stock for the coming years. 14 users see the criterium "Worthwhile Investment for the next years" as a plus for the Tilray Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Pros and Cons of Tilray Inc in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financials of Tilray, symbolized as TLRY, present a mixed bag, revealing both potential strengths and numerous challenges. With market dynamics heavily influencing the cannabis industry, it’s crucial to dissect Tilray’s financial metrics to derive meaningful insights. At first glance, the company showcases substantial revenue growth, but the underlying profitability and liquidity indicators suggest a need for strategic reevaluation. The question arises: Can Tilray navigate this tumultuous market landscape and emerge stronger, or are the financial challenges insurmountable?

Pros:

Revenue Growth: Tilray's revenue for the trailing twelve months (TTM) stands at approximately $788.94 million, reflecting a year-over-year quarterly revenue growth of 24.8%. This growth trend can instill confidence in investors, indicating that the company is capturing more market share.

Comments

Prediction Buy
Perf. (%) 0.49%
Target price 5.000
Change
Ends at 27.11.23

Target price set to 5.0
Show more

Buy Tilray Inc
Show more

Prediction Buy
Perf. (%) -63.46%
Target price
Change
Ends at 01.11.22

Buy Tilray Inc
Show more